BSR Insight | Bringing Medicines to Low-Income Markets
A new guide by the German Federal Ministry for Economic Cooperation and Development outlines how pharmaceutical companies can use inclusive business models to tap the growing market for pharmaceuticals in developing countries and improve the lives of the 1.7 billion people who lack access to essential medicines.
To help companies overcome some of the barriers to reaching low-income markets—including high costs for medicine, and a lack of qualified professionals, physical infrastructure, and health insurance—the guide offers the “4As+1” framework, which is based on acceptance, awareness, availability, and affordability, plus partnerships with NGOs and governments, among others.
More specifically, the report:
- Makes the case for pharmaceutical companies to venture into low-income markets
- Examines each of the “4As+1” with case studies illustrating the application of the framework in different contexts
- Offers practical guidance for how companies can reach low-income markets
About the Author(s)
Jessica Davis Pluess, Manager, Research
With strong knowledge of sustainability issues and rich experience in cross-sector collaboration, Jessica works with companies and BSR partners to explore meta-trends and key issues shaping sustainable development in the coming decades... Read more →
Share Your Thoughts
Please note, all comments are subject to moderation.